Literature DB >> 20731629

Cell-specific effects of variants of the 68-base pair tandem repeat on prodynorphin gene promoter activity.

Morgane Rouault1, David A Nielsen, Ann Ho, Mary Jeanne Kreek, Vadim Yuferov.   

Abstract

A polymorphic 68-bp tandem repeat has been identified within the promoter of the human prodynorphin (PDYN) gene. We found that this 68-bp repeat in the PDYN promoter occurs naturally up to five times. We studied the effect of the number of 68-bp repeats, and of a SNP (rs61761346) found within the repeat on PDYN gene promoter activity. Thirteen promoter forms, different naturally occurring combinations of repeats and the internal SNP, were cloned upstream of the luciferase reporter gene, transfected into human SK-N-SH, H69, or HEK293 cells. Cells were then stimulated with TPA or caffeine. We found cell-specific effects of the number of 68-bp repeats on the transcriptional activity of the PDYN promoter. In SK-N-SH and H69 cells, three or four repeats led to lower expression of luciferase than did one or two repeats. The opposite effect was found in HEK293 cells. The SNP also had an effect on PDYN gene expression in both SK-N-SH and H69 cells; promoter forms with the A allele had significantly higher expression than promoter forms with the G allele. These results further our understanding of the complex transcriptional regulation of the PDYN gene promoter.
© 2010 The Authors, Addiction Biology © 2010 Society for the Study of Addiction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20731629      PMCID: PMC2995810          DOI: 10.1111/j.1369-1600.2010.00248.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  42 in total

1.  Downstream regulatory element antagonistic modulator regulates islet prodynorphin expression.

Authors:  David A Jacobson; Julie Cho; Luis R Landa; Natalia A Tamarina; Michael W Roe; Joseph D Buxbaum; Louis H Philipson
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-04-18       Impact factor: 4.310

2.  Using TESS to predict transcription factor binding sites in DNA sequence.

Authors:  Jonathan Schug
Journal:  Curr Protoc Bioinformatics       Date:  2008-03

3.  An allelic variation in the human prodynorphin gene promoter alters stimulus-induced expression.

Authors:  A Zimprich; J Kraus; M Wöltje; P Mayer; E Rauch; V Höllt
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

4.  A functional polymorphism in the prodynorphin gene promotor is associated with temporal lobe epilepsy.

Authors:  Elisabeth Stögmann; Alexander Zimprich; Christoph Baumgartner; Susanne Aull-Watschinger; Volker Höllt; Fritz Zimprich
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

5.  Analysis of LGI1 promoter sequence, PDYN and GABBR1 polymorphisms in sporadic and familial lateral temporal lobe epilepsy.

Authors:  Giorgia Bovo; Erica Diani; Francesca Bisulli; Carlo Di Bonaventura; Pasquale Striano; Antonio Gambardella; Edoardo Ferlazzo; Gabriella Egeo; Oriano Mecarelli; Maurizio Elia; Amedeo Bianchi; Stefania Bortoluzzi; Andrea Vettori; Umberto Aguglia; Simona Binelli; Arturo De Falco; Giangennaro Coppola; Giuseppe Gobbi; Vito Sofia; Salvatore Striano; Paolo Tinuper; Anna T Giallonardo; Roberto Michelucci; Carlo Nobile
Journal:  Neurosci Lett       Date:  2008-03-04       Impact factor: 3.046

Review 6.  Dynorphin, stress, and depression.

Authors:  Allison T Knoll; William A Carlezon
Journal:  Brain Res       Date:  2009-09-24       Impact factor: 3.252

7.  Multiple Functional Variants in cis Modulate PDYN Expression.

Authors:  Courtney C Babbitt; Jesse S Silverman; Ralph Haygood; Jennifer M Reininga; Matthew V Rockman; Gregory A Wray
Journal:  Mol Biol Evol       Date:  2009-11-12       Impact factor: 16.240

8.  Opioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expression.

Authors:  Andrej Nikoshkov; Katarina Drakenberg; Xinyu Wang; Monika Cs Horvath; Eva Keller; Yasmin L Hurd
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-09       Impact factor: 11.205

9.  Position and distance specificity are important determinants of cis-regulatory motifs in addition to evolutionary conservation.

Authors:  Saran Vardhanabhuti; Junwen Wang; Sridhar Hannenhalli
Journal:  Nucleic Acids Res       Date:  2007-04-22       Impact factor: 16.971

10.  Transcriptionally less active prodynorphin promoter alleles are associated with temporal lobe epilepsy: a case-control study and meta-analysis.

Authors:  Marcelo A Kauffman; Damián Consalvo; Moron Dolores Gonzalez; Silvia Kochen
Journal:  Dis Markers       Date:  2008       Impact factor: 3.434

View more
  15 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

2.  Association of variants of prodynorphin promoter 68-bp repeats in caucasians with opioid dependence diagnosis: Effect on age trajectory of heroin use.

Authors:  Vadim Yuferov; Matthew Randesi; Eduardo R Butelman; Wim van den Brink; Peter Blanken; Jan M van Ree; Jürg Ott; Mary Jeanne Kreek
Journal:  Neurosci Lett       Date:  2019-03-29       Impact factor: 3.046

Review 3.  Genetics of opiate addiction.

Authors:  Brian Reed; Eduardo R Butelman; Vadim Yuferov; Matthew Randesi; Mary Jeanne Kreek
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

Review 4.  κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction.

Authors:  Eduardo R Butelman; Vadim Yuferov; Mary Jeanne Kreek
Journal:  Trends Neurosci       Date:  2012-06-16       Impact factor: 13.837

Review 5.  The genetics of the opioid system and specific drug addictions.

Authors:  Orna Levran; Vadim Yuferov; Mary Jeanne Kreek
Journal:  Hum Genet       Date:  2012-05-01       Impact factor: 4.132

6.  Tissue-specific DNA methylation of the human prodynorphin gene in post-mortem brain tissues and PBMCs.

Authors:  Vadim Yuferov; David A Nielsen; Orna Levran; Matthew Randesi; Sara Hamon; Ann Ho; Susan Morgello; Mary Jeanne Kreek
Journal:  Pharmacogenet Genomics       Date:  2011-04       Impact factor: 2.089

7.  Polymorphisms of the kappa opioid receptor and prodynorphin genes: HIV risk and HIV natural history.

Authors:  Dmitri Proudnikov; Matthew Randesi; Orna Levran; Vadim Yuferov; Howard Crystal; Ann Ho; Jurg Ott; Mary J Kreek
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

8.  Neuronal Expression of Opioid Gene is Controlled by Dual Epigenetic and Transcriptional Mechanism in Human Brain.

Authors:  Igor Bazov; Daniil Sarkisyan; Olga Kononenko; Hiroyuki Watanabe; Mumtaz Malik Taqi; Lada Stålhandske; Dineke S Verbeek; Jan Mulder; Grazyna Rajkowska; Donna Sheedy; Jillian Kril; Xueguang Sun; Ann-Christine Syvänen; Tatiana Yakovleva; Georgy Bakalkin
Journal:  Cereb Cortex       Date:  2018-09-01       Impact factor: 5.357

Review 9.  Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies.

Authors:  Alexandre A Guerin; Eric J Nestler; Michael Berk; Andrew J Lawrence; Susan L Rossell; Jee Hyun Kim
Journal:  Neurosci Biobehav Rev       Date:  2020-11-17       Impact factor: 8.989

Review 10.  Epigenetic and Transcriptional Control of the Opioid Prodynorphine Gene: In-Depth Analysis in the Human Brain.

Authors:  Olga Nosova; Igor Bazov; Victor Karpyak; Mathias Hallberg; Georgy Bakalkin
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.